Galectin ‐3 and risk of cardiovascular events and all‐cause mortality in type 2 diabetes

ConclusionsSerum galectin ‐3 is associated with adverse cardiovascular outcomes in persons with type 2 diabetes independent of traditional risk factors.

Source: Diabetes/Metabolism Research and Reviews - November 15, 2018 Category: Endocrinology Authors: Kathryn C.B. Tan, Ching ‐Lung Cheung, Alan C.H. Lee, Joanne K.Y. Lam, Ying Wong, Sammy W.M. Shiu Tags: RESEARCH ARTICLE Source Type: research